Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome- Associated Intestinal Pseudo-Obstruction

Cheng Zhang; Patel, Niravkumar J.; Jacobs, W. Carl; Ullman, Sonal; Berzin, Tyler M.; Chuttani, Ram; Lembo, Anthony J.; Wolf, Jacqueline L.
January 2013
Gastroenterology & Hepatology;Jan2013, Vol. 9 Issue 1, p48
Academic Journal
Case Study
Paraneoplastic syndromes are systemic disorders that are associated with malignancy but are not directly due to the local effects of a tumor mass or its metastases. These syndromes are most commonly associated with small cell lung cancer or thymoma. Paraneoplastic syndromes frequently present with gastrointestinal dysmotility and can lead to intestinal pseudo-obstruction. Many patients with paraneoplastic syndromes have detectable anti-Hu antibodies in the serum. We report a patient with non-small cell lung cancer who presented with pseudo- obstruction of the entire gastrointestinal tract that was successfully treated with intravenous immunoglobulin (IVIG) and subcutaneous mediylnaltrexone (Relistor, Salix).


Related Articles

  • Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility. Grover, Madhusudan; Camilleri, Michael // Gastroenterology & Hepatology;Jan2013, Vol. 9 Issue 1, p51 

    The article discusses the treatment for paraneoplastic gastrointestinal (GI) dysmotility with the use of intravenous immunoglobulin (IVIG) and methylnaltrexone. It says that motility disorder is described as paraneoplastic GI dysmotility and usually associated with small lung cancer (SCLC). It...

  • Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration. Schessl, J.; Schuberth, M.; Reilich, P.; Schneiderat, P.; Strigl-Pill, N.; Walter, M. C.; Schlotter-Weigel, B.; Schoser, B. // Journal of Neurology;May2011, Vol. 258 Issue 5, p946 

    A letter to the editor is presented which discusses the efficiency of long-term intravenous immunoglobulin (IVIG) treatment in a 72-year-old female patient diagnosed with anti-Yo syndrome, also known as Purkinje cell antibodies type 1 (PCA-1), and paraneoplastic cerebellar degeneration (PCD)...

  • S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors. BLANKE, CHARLES D.; RANKIN, CATHY; CORLESS, CHRISTOPHER; EARY, JANET F.; MULDER, KAREN; OKUNO, SCOTT H.; GEORGE, SUZANNE; HEINRICH, MICHAEL // Oncologist;Dec2015, Vol. 20 Issue 12, p1353 

    Background. Imatinib mesylate, a potent inhibitor of the KIT and PDGFR tyrosine kinases, is highly effective in the treatment of advanced gastrointestinal stromal tumors (GISTs). However, most imatinib-treated tumors eventually become resistant, accounting for a median progression-free survival...

  • Endometrial Adenocarcinoma Metastasis to Nasal Skin. Sezen, Ozan Seymen; Eraslan, Gülüzar; Coskuner, Temel; Yavuzer, Dilek; Bilici, Ahmet; Bilge, Saliha; Keser, Sevinc Hallac; Gumus, Mahmut; Unver, Seref // Journal of Otolaryngology -- Head & Neck Surgery;Apr2010, Vol. 39 Issue 2, pE8 

    The article describes the case of a 67-year-old female patient who was diagnosed with endometrial adenocarcinoma with metastasis to nasal skin. It cites that the positron-emission tomography-computed tomography (PET-CT) scan revealed that she had pulmonary metastatic nodules. The reason why...

  • Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer. Keating, Gillian M. // Drugs;2012, Vol. 72 Issue 3, p353 

    The humanized monoclonal antibody pertuzu-mab is the first in a new class of drugs, the human epidermal growth factor receptor (HER) dimeriza-tion inhibitors. Given that pertuzumab binds to a different epitope of the HER2 extracellular domain than trastuzumab, combination therapy with...

  • Clinical Uses of Intravenous Immunoglobulins. Berkman, Samuel A.; Lee, Martin L.; Gale, Robert Peter // Annals of Internal Medicine;2/15/90, Vol. 112 Issue 4, p278 

    Presents a study which ascertained the activity of intravenous immunoglobulin in a wide range of diseases. Ideal intravenous immunoglobulin preparation; Proposed mechanism of action in immune deficiency, immune regulatory disorders and bacterial and viral infections; Infections associated with...

  • Extrahepatic Manifestations of Acute Hepatitis B Virus Infection. Kappus, Matthew R.; Sterling, Richard K. // Gastroenterology & Hepatology;Feb2013, Vol. 9 Issue 2, p123 

    A review of the article "Extrahepatic Manifestations of Acute Hepatitis B Virus Infection," by Matthew R. Kappus and Richard K. Sterling, which appeared in the journal "Gastroenterology & Hepatology" on February 2, 2013, is presented.

  • Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity. Yingbing Wang; Carter, Brett W.; Muse, Victorine; Digumarthy, Subba; Shepard, Jo-Anne; Sharma, Amita // Lung Cancer International;2013, p1 

    Objective. Talc pleurodesis is a common procedure performed to treat complications related to lung cancer. The purpose of our study was to characterize any thoracic nodal findings on FDG PET/CT associated with prior talc pleurodesis. Materials and Methods. The electronic medical record...

  • Subcutaneous immunoglobulins in ocular myositis. Danieli, Maria Giovanna; Moretti, Romina; Pettinari, Lucia; Gabrielli, Armando // Rheumatology;Apr2012, Vol. 51 Issue 4, p764 

    A letter to the editor about the case of a young boy who was diagnosed with ocular myositis and treated with subcutaneous immunoglobulin (SCIg) is presented. The medical history of the patient is detailed. Recurrences experienced by the patient were attributed to airway infections. The addition...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics